Fujirebio is a global leader in the field of high quality in vitro diagnostics (IVD). It has more than 50 years’ accumulated experience in the conception, development, production and worldwide commercialization of robust IVD products. Founded in 1950 in Tokyo, Japan, Fujirebio has over the years concluded a number of successful acquisitions of best-in-class IVD companies. Examples include Centocor Diagnostics in 1998, CanAg Diagnostics in 2006 and Innogenetics in 2010. Today, Fujirebio’s global presence includes offices in the United States, Latin America, Europe and Asia as well as a vast international distribution network. Fujirebio has a strong and long-lasting tradition of collaborating with experts in the worldwide clinical community in the development of high-quality routine and truly novel biomarkers that cover a variety of disease states. Its IVD product lines span the range from specialized manual and automated testing to fully automated routine clinical laboratory testing solutions. Fujirebio is today a consolidated subsidiary of H.U. Group Holdings, Inc. (listed on the Tokyo Stock Exchange – TYO: 4544) and employs more than 1,200 people in Asia, Europe and America.

Noramco, headquartered in Wilmington, Delaware, is a global leader in the production of controlled substances for the pharmaceutical industry, for medicines used to treat attention deficit hyperactivity disorder, pain, addiction, and for abuse-deterrent formulations. We realize our success through a keen focus on commercial and operational excellence as well as continuing strategic growth. Our global footprint includes Athens, GA, Wilmington, DE and Neuhausen, Switzerland. Specialists in controlled substance development and manufacturing, Noramco is a partner to the pharmaceutical industry: – Focusing on high-purity controlled substances – Leveraging intellectual property to devise the most efficient routes to APIs – Providing analytical data, chemical and physical properties, stability studies and regulatory assistance – Formulation friendly particle size grades and extended technical packages – Delivering DEA-compliant security and production capacity, from kilos to multi-ton supply – Supporting world-class supply security of controlled-substances, from schedule I to schedule III

Lebanon Seaboard Corporation is a family-owned business that has been a key supplier of home lawn and garden products, and wild bird food for homeowners across America and professional lawn & landscape products, and golf & sports turf products globally, for over 70 years. Primary consumer brands are Preen Garden Weed Preventer products, GreenView lawn care products and Lyric Wild Bird Food products. Recognized Professional turf brands include Lebanon ProScape, Country Club MD and a variety of proprietary ingredient brands.

Pharmaceutics International, Inc. (Pii) Concept-to-Clinic-to-Commercialization Pharmaceutics Know-How™. Pharmaceutics International, Inc. (Pii) is a science-driven contract development and manufacturing organization (CDMO) located in Hunt Valley, MD, USA, offering unparalleled scientific insight and depth of product knowledge to supply high-quality dosage forms that enhance the lives of patients worldwide. Founded in 1994, Pii has grown from 12 employees to more than 270 scientists and support staff. With more than 360,000 square feet of operating space, Pii's cGMP and DEA-registered facilities are state-of-the-art. More than 70 manufacturing suites include containment areas for handling high potency compounds and hormones, dedicated manufacturing suites for oral products (e.g., soft gels) and injectables (e.g., vials, syringes, cartridges), a formulation development center, and analytical and micro laboratories.

Immunocore is a leading T cell receptor (TCR) biotechnology company working to create first-in-class biological therapies to address unmet patient needs in oncology as well as infectious and autoimmune diseases. See our community guidelines: http://bit.ly/2kFA8hr

For 60 years, Coim has been an international leader in the production of polyesters and polyols, polyurethanes, and specialty resins. Thanks to a global approach and local presence, Coim is able to support a vast range of applications and enhance the daily life of many end users. Technologically advanced plants, strict procedures, a commitment to research and development, and a passion for a sustainable future are all factors enabling us to guarantee a high standard of quality and innovative products. We pride ourselves in having an innovative, flexible approach and always working in close partnership with our customers. Our mission is to continue to grow, developing our presence in the world of polyurethanes and chemical specialties in accordance with the values we have always held dear: care and respect for our stakeholders and the Environment. Coim Group has a clear purpose: to create the ideal conditions for a better quality of life.

Private Label service oriented packaging company. Aerosol and Bulk Packaging available! Automotive Aftermarket Lubricants / Penetrants Cleaners / Degreasers Adhesives Specialty Paints & Coatings Manufacturing in Plymouth Meeting, PA and Medina, OH Distribution in PA, OH and CA.

Quip Laboratories is the industry standard for biosafety management. With the most innovative equipment, chemical and services, Quip Laboratories provides excellent solutions to simplify your facility's hygiene solutions. In other words: Quip makes it safe. Simply and sensibly.

mdi is a manufacturer of membranes and membrane based products for filtration and separation applications for Biopharmaceutical/Pharmaceutical and Rapid Diagnostics Industries. The company has a history and experience of more than 35 years in membrane production and filtration technology with Sales in more than 50 countries globally. With its state of the art GMP manufacturing facility and extensive product range the company competes with all the major players in the Industry and strives to gain a leadership position on a global scale. mdi production facilities are ISO 9001:2008 certified and some products are ISO 13485 certified for medical use. mdi has a Drug Master File submitted with US FDA. The products meet all stringent demands related to Toxicity, Biosafety, Extractables etc. relevant for the Pharma and Biopharma applications. mdi offers a wide range of high quality, tested and validated products to address all customer needs for Dead-end filtration. Over the years mdi has helped customers to achieve substantial cost savings with its cost effective products and solutions. The ability to deliver customized products and solutions to solve specific problems has always been a differentiator for mdi over competition.